Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Abbott's new LHRH antagonists, pharmaceutical compositions and use

Nov. 26, 1999

Novel antitumor agents for both leukemias and solid tumors discovered by Taiwanese scientists

Nov. 26, 1999

Xenova's IND for multidrug resistance modulator gets FDA approval

Nov. 26, 1999

AACR-NCI-EORTC news: Japanese research team presents new hypoxic cell radiosensitizing agent

Nov. 25, 1999

Mount Sinai investigators describe novel apoptosis-inducing agent at scientific forum

Nov. 25, 1999

BASF discloses protein kinase inhibitors useful as antiangiogenic agents

Nov. 25, 1999

Calcium entry blockers with potential in the treatment of prostate cancer

Nov. 25, 1999

Valentis initiates phase IIa trial of IFN-alpha gene medicine in angiosarcoma

Nov. 25, 1999

Combination therapy containing GTI-2040 shows remarkable antitumor activity

Nov. 25, 1999

More promising cancer news from AACR-NCI-EORTC: Hughes Institute presents new compounds

Nov. 24, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 9, 2026.
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
ASCO 2026: Chinese biopharma arrives at ASCO with pivotal wins
BioWorld
If the 2026 American Society of Clinical Oncology (ASCO) annual meeting in Chicago from May 30 to June 3 demonstrated anything about the evolution of China’s...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...